Annovis Bio closes common stock purchase agreement with equity line investor

Annovis Bio, Inc.

Closed transactions contemplated by Common Stock Purchase Agreement entered April 25, 2024.
Equity line investor purchased shares; no specific dollar amount or share count disclosed.
Loeb & Loeb LLP opinion on securities issuance filed as Exhibit 5.1.

item 8.01 item 9.01

Annovis Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-24-006534

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.